{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:42:09Z","timestamp":1767339729349,"version":"3.37.3"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00428-023-03585-8","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:02:19Z","timestamp":1691658139000},"page":"591-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology"],"prefix":"10.1007","volume":"483","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-9206","authenticated-orcid":false,"given":"Snjezana","family":"Dotlic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-6442","authenticated-orcid":false,"given":"Sarah E.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-1091","authenticated-orcid":false,"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-4067","authenticated-orcid":false,"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-930X","authenticated-orcid":false,"given":"Monika","family":"Klimkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socorro Maria","family":"Rodriguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-3591","authenticated-orcid":false,"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-1086","authenticated-orcid":false,"given":"Thomas A.","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-4060","authenticated-orcid":false,"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-9995","authenticated-orcid":false,"given":"Stefan","family":"Dojcinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"issue":"8","key":"3585_CR1","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/28.8.7003001","volume":"28","author":"H Stein","year":"1980","unstructured":"Stein H, Bonk A, Tolksdorf G, Lennert K, Rodt H, Gerdes J (1980) Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin\u2019s lymphomas. J Histochem Cytochem 28(8):746\u2013760","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"3585_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1182\/blood.V65.2.305.305","volume":"65","author":"PR Greipp","year":"1985","unstructured":"Greipp PR, Raymond NM, Kyle RA, O\u2019Fallon WM (1985) Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 65(2):305\u2013310","journal-title":"Blood"},{"issue":"4","key":"3585_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413\u20131420","journal-title":"Blood"},{"issue":"6","key":"3585_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-2559.2007.02870.x","volume":"51","author":"J Borenstein","year":"2007","unstructured":"Borenstein J, Pezzella F, Gatter KC (2007) Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 51(6):774\u2013777","journal-title":"Histopathology"},{"issue":"9","key":"3585_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.mpdhp.2020.07.001","volume":"26","author":"G Leopold","year":"2020","unstructured":"Leopold G, Dotlic S, Mahdi A, Pugh M, Dojcinov S (2020) Differential diagnosis of aggressive neoplasms with plasmablastic and late post-follicular differentiation. Diagn Histopathol 26(9):421\u2013439","journal-title":"Diagn Histopathol"},{"issue":"4","key":"3585_CR6","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","volume":"95","author":"N Dupin","year":"2000","unstructured":"Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406\u20131412","journal-title":"Blood"},{"issue":"9","key":"3585_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1182\/blood.2020009746","volume":"137","author":"J Moreaux","year":"2021","unstructured":"Moreaux J (2021) The origin of preplasmablastic cells. Blood 137(9):1134\u20131135","journal-title":"Blood"},{"issue":"6","key":"3585_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","volume":"28","author":"L Colomo","year":"2004","unstructured":"Colomo L, Loong F, Rives S, Pittaluga S, Mart\u00ednez A, L\u00f3pez-Guillermo A et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736\u2013747","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3585_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/sj.leu.2403206","volume":"18","author":"I Simonitsch-Klupp","year":"2004","unstructured":"Simonitsch-Klupp I, Hauser I, Ott G, Drach J, Ackermann J, Kaufmann J et al (2004) Diffuse large B-cell lymphomas with plasmablastic\/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 18(1):146\u2013155","journal-title":"Leukemia"},{"issue":"2","key":"3585_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10428194.2011.608447","volume":"53","author":"S Montes-Moreno","year":"2012","unstructured":"Montes-Moreno S, Montalb\u00e1n C, Piris MA (2012) Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma 53(2):185\u2013194","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"3585_CR11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2353\/ajpath.2009.080848","volume":"174","author":"O Balague","year":"2009","unstructured":"Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL et al (2009) Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications. Am J Pathol 174(6):2337\u20132346","journal-title":"Am J Pathol"},{"issue":"1","key":"3585_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00428-022-03466-6","volume":"482","author":"JY Song","year":"2023","unstructured":"Song JY, Dirnhofer S, Piris MA, Quintanilla-Martinez L, Pileri S, Campo E (2023) Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities. Virchows Arch 482(1):179\u2013192","journal-title":"Virchows Arch"},{"issue":"7","key":"3585_CR13","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u201348","journal-title":"Leukemia"},{"issue":"11","key":"3585_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229\u20131253","journal-title":"Blood"},{"issue":"22","key":"3585_CR15","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1182\/blood-2010-09-307710","volume":"117","author":"K Vrzalikova","year":"2011","unstructured":"Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A et al (2011) Down-regulation of BLIMP1alpha by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas. Blood 117(22):5907\u20135917","journal-title":"Blood"},{"key":"3585_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clim.2017.10.002","volume":"187","author":"J DeFalco","year":"2018","unstructured":"DeFalco J, Harbell M, Manning-Bog A, Baia G, Scholz A, Millare B et al (2018) Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens. Clin Immunol 187:37\u201345","journal-title":"Clin Immunol"},{"issue":"7","key":"3585_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","volume":"38","author":"J Morscio","year":"2014","unstructured":"Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X et al (2014) Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 38(7):875\u2013886","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3585_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","volume":"37","author":"D Martinez","year":"2013","unstructured":"Martinez D, Valera A, Perez NS, Sua Villegas LF, Gonzalez-Farre B, Sole C et al (2013) Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases. Am J Surg Pathol 37(2):272\u2013281","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"3585_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajh.21250","volume":"83","author":"J Castillo","year":"2008","unstructured":"Castillo J, Pantanowitz L, Dezube BJ (2008) HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 83(10):804\u2013809","journal-title":"Am J Hematol"},{"issue":"10","key":"3585_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","volume":"140","author":"CM Harmon","year":"2016","unstructured":"Harmon CM, Smith LB (2016) Plasmablastic lymphoma: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med 140(10):1074\u20131078","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"3585_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ajh.21259","volume":"83","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A (2008) Plasmablastic lymphoma: one or more entities? Am J Hematol 83(10):763\u2013764","journal-title":"Am J Hematol"},{"issue":"7","key":"3585_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/modpathol.2010.72","volume":"23","author":"L Taddesse-Heath","year":"2010","unstructured":"Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES (2010) Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol 23(7):991\u2013999","journal-title":"Mod Pathol"},{"issue":"11","key":"3585_CR23","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/leu.2015.109","volume":"29","author":"J Chapman","year":"2015","unstructured":"Chapman J, Gentles AJ, Sujoy V, Vega F, Dumur CI, Blevins TL et al (2015) Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs. Leukemia 29(11):2270\u20132273","journal-title":"Leukemia"},{"issue":"4","key":"3585_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","volume":"106","author":"J Garcia-Reyero","year":"2021","unstructured":"Garcia-Reyero J, Martinez Magunacelaya N, Gonzalez de Villambrosia S, Loghavi S, Gomez Mediavilla A, Tonda R et al (2021) Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. Haematologica 106(4):1120\u20138","journal-title":"Haematologica"},{"issue":"10","key":"3585_CR25","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","volume":"106","author":"JE Ramis-Zaldivar","year":"2021","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F et al (2021) MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica 106(10):2682\u20132693","journal-title":"Haematologica"},{"key":"3585_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.humpath.2020.06.001","volume":"102","author":"AM Maeshima","year":"2020","unstructured":"Maeshima AM, Taniguchi H, Ida H, Hosoba R, Fujino T, Saito Y et al (2020) Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases. Hum Pathol 102:33\u201343","journal-title":"Hum Pathol"},{"issue":"6","key":"3585_CR27","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1309\/AJCPWY1SGJ9IEAOR","volume":"134","author":"I Ouansafi","year":"2010","unstructured":"Ouansafi I, He B, Fraser C, Nie K, Mathew S, Bhanji R et al (2010) Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol 134(6):972\u2013981","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"3585_CR28","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.humpath.2013.04.008","volume":"44","author":"Z Pan","year":"2013","unstructured":"Pan Z, Xie Q, Repertinger S, Richendollar BG, Chan WC, Huang Q (2013) Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements. Hum Pathol 44(10):2139\u20132148","journal-title":"Hum Pathol"},{"issue":"6","key":"3585_CR29","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/PAI.0000000000000441","volume":"25","author":"A Ronchi","year":"2017","unstructured":"Ronchi A, Marra L, Frigeri F, Botti G, Franco R, De Chiara A (2017) Richter syndrome with plasmablastic lymphoma at primary diagnosis: a case report with a review of the literature. Appl Immunohistochem Mol Morphol 25(6):e40\u2013e45","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5\u20136","key":"3585_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1034\/j.1600-0609.2001.00592.x","volume":"67","author":"T Robak","year":"2001","unstructured":"Robak T, Urbanska-Rys H, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ et al (2001) Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter\u2019s syndrome. Eur J Haematol 67(5\u20136):322\u2013327","journal-title":"Eur J Haematol"},{"issue":"2","key":"3585_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bjh.13562","volume":"171","author":"AG Evans","year":"2015","unstructured":"Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW et al (2015) Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells. Br J Haematol 171(2):205\u2013209","journal-title":"Br J Haematol"},{"issue":"1","key":"3585_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000505683","volume":"13","author":"G Gasljevic","year":"2020","unstructured":"Gasljevic G, Grat M, Kloboves Prevodnik V, Grcar Kuzmanov B, Gazic B, Lovrecic L et al (2020) Chronic lymphocytic leukemia with divergent Richter\u2019s transformation into a clonally related classical Hodgkin\u2019s and Plasmablastic lymphoma: a case report. Case Rep Oncol 13(1):120\u2013129","journal-title":"Case Rep Oncol"},{"key":"3585_CR33","first-page":"2861596","volume":"2017","author":"E Hatzimichael","year":"2017","unstructured":"Hatzimichael E, Papathanasiou K, Zerdes I, Flindris S, Papoudou-Bai A, Kapsali E (2017) Plasmablastic lymphoma with coexistence of chronic lymphocytic leukemia in an immunocompetent patient: a case report and mini-review. Case Rep Hematol 2017:2861596","journal-title":"Case Rep Hematol"},{"issue":"12","key":"3585_CR34","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1200\/JCO.2012.46.9593","volume":"31","author":"BM Holderness","year":"2013","unstructured":"Holderness BM, Malhotra S, Levy NB, Danilov AV (2013) Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia. J Clin Oncol 31(12):e197\u2013e199","journal-title":"J Clin Oncol"},{"issue":"2","key":"3585_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bjh.14062","volume":"177","author":"KL Chan","year":"2017","unstructured":"Chan KL, Blombery P, Jones K, Lade S, Carney D, Tran H et al (2017) Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors. Br J Haematol 177(2):324\u2013328","journal-title":"Br J Haematol"},{"issue":"1","key":"3585_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pathol.2021.04.008","volume":"54","author":"A Gango","year":"2022","unstructured":"Gango A, Kiss R, Farkas P, Hanna E, Demeter J, Deak B et al (2022) Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology 54(1):95\u2013103","journal-title":"Pathology"},{"issue":"8","key":"3585_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","volume":"95","author":"S Montes-Moreno","year":"2010","unstructured":"Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G et al (2010) Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 95(8):1342\u20131349","journal-title":"Haematologica"},{"issue":"2","key":"3585_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1309\/AJCPV1I2QWKZKNJH","volume":"136","author":"ED Hsi","year":"2011","unstructured":"Hsi ED, Lorsbach RB, Fend F, Dogan A (2011) Plasmablastic lymphoma and related disorders. Am J Clin Pathol 136(2):183\u2013194","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"3585_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0609.1995.tb00204.x","volume":"54","author":"M Sailer","year":"1995","unstructured":"Sailer M, Vykoupil KF, Peest D, Coldewey R, Deicher H, Georgii A (1995) Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol 54(3):137\u2013146","journal-title":"Eur J Haematol"},{"issue":"3","key":"3585_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","volume":"87","author":"R Bartl","year":"1987","unstructured":"Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W (1987) Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 87(3):342\u201355","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"3585_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","volume":"128","author":"ST Chang","year":"2007","unstructured":"Chang ST, Liao YL, Lu CL, Chuang SS, Li CY (2007) Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV. Am J Clin Pathol 128(2):339\u2013344","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"3585_CR42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/apm.12411","volume":"123","author":"HE Moller","year":"2015","unstructured":"Moller HE, Preiss BS, Pedersen P, Kristensen IB, Hansen CT, Frederiksen M et al (2015) Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort. APMIS 123(8):652\u2013658","journal-title":"APMIS"},{"issue":"7","key":"3585_CR43","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","volume":"91","author":"PR Greipp","year":"1998","unstructured":"Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA et al (1998) Plasmablastic morphology\u2013an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood 91(7):2501\u20132507","journal-title":"Blood"},{"issue":"5","key":"3585_CR44","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1200\/JCO.1999.17.5.1551","volume":"17","author":"SV Rajkumar","year":"1999","unstructured":"Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA et al (1999) Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol 17(5):1551\u20131557","journal-title":"J Clin Oncol"},{"issue":"2","key":"3585_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00428-022-03342-3","volume":"481","author":"BJ Chen","year":"2022","unstructured":"Chen BJ, Yuan CT, Yang CF, Ho CH, Lin YK, Su YZ et al (2022) Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma. Virchows Arch 481(2):283\u2013293","journal-title":"Virchows Arch"},{"issue":"1","key":"3585_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00428-022-03431-3","volume":"482","author":"F Fend","year":"2023","unstructured":"Fend F, Dogan A, Cook JR (2023) Plasma cell neoplasms and related entities-evolution in diagnosis and classification. Virchows Arch 482(1):163\u2013177","journal-title":"Virchows Arch"},{"issue":"5","key":"3585_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/sj.leu.2404172","volume":"20","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Santana-Davila R, Van Wier SA, Ahmann GJ, Jalal SM, Bergsagel PL et al (2006) Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia 20(5):807\u2013813","journal-title":"Leukemia"},{"issue":"4","key":"3585_CR48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","volume":"64","author":"R Fonseca","year":"2004","unstructured":"Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64(4):1546\u20131558","journal-title":"Cancer Res"},{"issue":"4","key":"3585_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3324\/haematol.12005","volume":"93","author":"K Bink","year":"2008","unstructured":"Bink K, Haralambieva E, Kremer M, Ott G, Beham-Schmid C, de Leval L et al (2008) Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica 93(4):623\u2013626","journal-title":"Haematologica"},{"issue":"11","key":"3585_CR50","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balague O, Colomo L, Martinez A, Delabie J, Taddesse-Heath L et al (2010) IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34(11):1686\u20131694","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"3585_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ijlh.12360","volume":"37","author":"M Chesi","year":"2015","unstructured":"Chesi M, Bergsagel PL (2015) Advances in the pathogenesis and diagnosis of multiple myeloma. Int J Lab Hematol 37(Suppl 1):108\u2013114","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"3585_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12185-013-1291-2","volume":"97","author":"M Chesi","year":"2013","unstructured":"Chesi M, Bergsagel PL (2013) Molecular pathogenesis of multiple myeloma: basic and clinical updates. Int J Hematol 97(3):313\u2013323","journal-title":"Int J Hematol"},{"issue":"6","key":"3585_CR53","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/PAS.0000000000000213","volume":"38","author":"R Xiao","year":"2014","unstructured":"Xiao R, Cerny J, Devitt K, Dresser K, Nath R, Ramanathan M et al (2014) MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS). Am J Surg Pathol 38(6):776\u2013783","journal-title":"Am J Surg Pathol"},{"key":"3585_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jncimonographs\/lgn011","volume":"39","author":"A Dib","year":"2008","unstructured":"Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM (2008) Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr 39:25\u201331","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"3585_CR55","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/PAS.0000000000001459","volume":"44","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jelloul F, Zhang Y, Bhavsar T, Ho C, Rao M et al (2020) Genetic basis of extramedullary plasmablastic transformation of multiple myeloma. Am J Surg Pathol 44(6):838\u2013848","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3585_CR56","first-page":"2119","volume":"9","author":"HJ Weh","year":"1995","unstructured":"Weh HJ, Bartl R, Seeger D, Selbach J, Kuse R, Hossfeld DK (1995) Correlations between karyotype and cytologic findings in multiple myeloma. Leukemia 9(12):2119\u20132122","journal-title":"Leukemia"},{"issue":"10","key":"3585_CR57","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1097\/PAS.0000000000001113","volume":"42","author":"S Gong","year":"2018","unstructured":"Gong S, Crane GM, McCall CM, Xiao W, Ganapathi KA, Cuka N et al (2018) Expanding the spectrum of EBV-positive marginal zone lymphomas: a lesion associated with diverse immunodeficiency settings. Am J Surg Pathol 42(10):1306\u20131316","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3585_CR58","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/leu.2011.156","volume":"25","author":"D Lenze","year":"2011","unstructured":"Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T et al (2011) The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia 25(12):1869\u20131876","journal-title":"Leukemia"},{"issue":"2","key":"3585_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/his.12640","volume":"67","author":"S Loghavi","year":"2015","unstructured":"Loghavi S, Khoury JD, Medeiros LJ (2015) Epstein-Barr virus-positive plasmacytoma in immunocompetent patients. Histopathology 67(2):225\u2013234","journal-title":"Histopathology"},{"issue":"10","key":"3585_CR60","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0000000000001923","volume":"46","author":"T Zhou","year":"2022","unstructured":"Zhou T, Cheng J, Karrs J, Davies-Hill T, Pack SD, Xi L et al (2022) Clinicopathologic and molecular characterization of Epstein-Barr Virus-positive plasmacytoma. Am J Surg Pathol 46(10):1364\u20131379","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"3585_CR61","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1634\/theoncologist.12-5-569","volume":"12","author":"YB Chen","year":"2007","unstructured":"Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12(5):569\u2013576","journal-title":"Oncologist"},{"key":"3585_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-230X(01)80014-2","volume":"80","author":"G Gaidano","year":"2001","unstructured":"Gaidano G, Carbone A (2001) Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv Cancer Res 80:115\u2013146","journal-title":"Adv Cancer Res"},{"key":"3585_CR63","doi-asserted-by":"crossref","unstructured":"Hu Z, Pan Z, Chen W, Shi Y, Wang W, Yuan J, et al. (2021) Primary effusion lymphoma: a clinicopathological study of 70 cases. Cancers (Basel) 13(4)","DOI":"10.3390\/cancers13040878"},{"issue":"4","key":"3585_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncr.23597","volume":"114","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A (2008) PEL and HHV8-unrelated effusion lymphomas: classification and diagnosis. Cancer 114(4):225\u2013227","journal-title":"Cancer"},{"issue":"23","key":"3585_CR65","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1182\/blood-2013-07-515882","volume":"122","author":"JY Song","year":"2013","unstructured":"Song JY, Jaffe ES (2013) HHV-8-positive but EBV-negative primary effusion lymphoma. Blood 122(23):3712","journal-title":"Blood"},{"issue":"10","key":"3585_CR66","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jcp.2005.026542","volume":"58","author":"A Carbone","year":"2005","unstructured":"Carbone A, Gloghini A, Vaccher E, Marchetti G, Gaidano G, Tirelli U (2005) KSHV\/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype. J Clin Pathol 58(10):1039\u201345","journal-title":"J Clin Pathol"},{"issue":"2","key":"3585_CR67","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J et al (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus. Blood 88(2):645\u2013656","journal-title":"Blood"},{"issue":"2","key":"3585_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ajh.24251","volume":"91","author":"S Guillet","year":"2016","unstructured":"Guillet S, Gerard L, Meignin V, Agbalika F, Cuccini W, Denis B et al (2016) Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution. Am J Hematol 91(2):233\u2013237","journal-title":"Am J Hematol"},{"issue":"8","key":"3585_CR69","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/PAS.0b013e31825b38ec","volume":"36","author":"ZG Pan","year":"2012","unstructured":"Pan ZG, Zhang QY, Lu ZB, Quinto T, Rozenvald IB, Liu LT et al (2012) Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Am J Surg Pathol 36(8):1129\u20131140","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3585_CR70","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/his.13449","volume":"72","author":"BJ Chen","year":"2018","unstructured":"Chen BJ, Wang RC, Ho CH, Yuan CT, Huang WT, Yang SF et al (2018) Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association. Histopathology 72(6):930\u2013944","journal-title":"Histopathology"},{"issue":"1","key":"3585_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41379-019-0365-y","volume":"33","author":"F Vega","year":"2020","unstructured":"Vega F, Miranda RN, Medeiros LJ (2020) KSHV\/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap. Mod Pathol 33(1):18\u201328","journal-title":"Mod Pathol"},{"issue":"1408","key":"3585_CR72","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1098\/rstb.2000.0778","volume":"356","author":"C Boshoff","year":"2001","unstructured":"Boshoff C, Weiss RA (2001) Epidemiology and pathogenesis of Kaposi\u2019s sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356(1408):517\u2013534","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"7","key":"3585_CR73","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC et al (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99(7):2331\u20132336","journal-title":"Blood"},{"issue":"2","key":"3585_CR74","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/QAI.0b013e3182a8338f","volume":"65","author":"M Bower","year":"2014","unstructured":"Bower M, Pria AD, Coyle C, Nelson M, Naresh K (2014) Diagnostic criteria schemes for multicentric Castleman disease in 75 cases. J Acquir Immune Defic Syndr 65(2):e80\u2013e82","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"3585_CR75","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/modpathol.2016.233","volume":"30","author":"B Gonzalez-Farre","year":"2017","unstructured":"Gonzalez-Farre B, Martinez D, Lopez-Guerra M, Xipell M, Monclus E, Rovira J et al (2017) HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma. Mod Pathol 30(5):745\u2013760","journal-title":"Mod Pathol"},{"issue":"8","key":"3585_CR76","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/pin.12951","volume":"70","author":"Y Nakaya","year":"2020","unstructured":"Nakaya Y, Ishii N, Kasamatsu Y, Shimizu K, Tatsumi N, Tsutsumi M et al (2020) Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder. Pathol Int 70(8):574\u2013580","journal-title":"Pathol Int"},{"issue":"10","key":"3585_CR77","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00277-020-04024-3","volume":"99","author":"M Zanelli","year":"2020","unstructured":"Zanelli M, Zizzo M, Bisagni A, Froio E, De Marco L, Valli R et al (2020) Germinotropic lymphoproliferative disorder: a systematic review. Ann Hematol 99(10):2243\u20132253","journal-title":"Ann Hematol"},{"issue":"3","key":"3585_CR78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/PAS.0000000000000775","volume":"41","author":"DF Boyer","year":"2017","unstructured":"Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA et al (2017) Fibrin-associated EBV-positive Large B-Cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol 41(3):299\u2013312","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3585_CR79","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.carpath.2014.08.007","volume":"24","author":"C Aguilar","year":"2015","unstructured":"Aguilar C, Beltran B, Qui\u00f1ones P, Carbajal T, Vilcapaza J, Yabar A et al (2015) Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 24(1):60\u201364","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"3585_CR80","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010) EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34(3):405\u2013417","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3585_CR81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","volume":"159","author":"SD Dojcinov","year":"2023","unstructured":"Dojcinov SD, Quintanilla-Martinez L (2023) How I diagnose EBV-positive B- and T-cell lymphoproliferative disorders. Am J Clin Pathol 159(1):14\u201333","journal-title":"Am J Clin Pathol"},{"issue":"26","key":"3585_CR82","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","volume":"122","author":"MN Polizzotto","year":"2013","unstructured":"Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V et al (2013) Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 122(26):4189\u20134198","journal-title":"Blood"},{"issue":"3","key":"3585_CR83","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1086\/654798","volume":"51","author":"TS Uldrick","year":"2010","unstructured":"Uldrick TS, Wang V, O\u2019Mahony D, Aleman K, Wyvill KM, Marshall V et al (2010) An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 51(3):350\u2013358","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3585_CR84","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/ejh.12191","volume":"91","author":"E Oksenhendler","year":"2013","unstructured":"Oksenhendler E, Boutboul D, Beldjord K, Meignin V, de Labarthe A, Fieschi C et al (2013) Human herpesvirus 8+ polyclonal IgMlambda B-cell lymphocytosis mimicking plasmablastic leukemia\/lymphoma in HIV-infected patients. Eur J Haematol 91(6):497\u2013503","journal-title":"Eur J Haematol"},{"issue":"5","key":"3585_CR85","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12185-020-02897-8","volume":"112","author":"S Sanchez","year":"2020","unstructured":"Sanchez S, Veloza L, Wang L, Lopez M, Lopez-Guillermo A, Marginet M et al (2020) HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders. Int J Hematol 112(5):734\u2013740","journal-title":"Int J Hematol"},{"issue":"5","key":"3585_CR86","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/modpathol.2009.36","volume":"22","author":"JA Ferry","year":"2009","unstructured":"Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL (2009) HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma. Mod Pathol 22(5):618\u2013626","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03585-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:04:11Z","timestamp":1700813051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3585"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03585-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare strict compliance with ethical standards. Any additional studies were conducted with the approval of the Medical Ethical Committee of AmsterdamUMC\/VUMC (registration 2020.343).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}